BIODENT
ActiveFinancials · financial year 2025, abbreviated format
Annual accounts 2025 filed on 06-07-2026 at the NBB all 2 filings
2024 to 2025, 2 financial years
The operating result for 2025 is a profit of €79,925, after a loss of €65,008 in 2024.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Average staff per financial year, in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio, return on assets (ROA) and staff (FTE).
Staff
| Item | 31-12-2024 | 31-12-2025 |
|---|---|---|
| Employees at the balance-sheet date | 2 | 6 |
| full-time | 1 | 2 |
| part-time | 1 | 4 |
| in full-time equivalents | 1.8 | 4 |
| Average over the year, in full-time equivalents | 1.2 | 3.2 |
| On a permanent contract | 2 | 6 |
| Joined | 2 | 5 |
| Left | 0 | 1 |
Source: social balance sheet in the 2024 to 2025 annual accounts
Securities and guarantees
| Item | 2024 | 2025 |
|---|---|---|
| Debts secured on the company's own assets | €1.9m | €1.7m |
| Mortgages, amount registered | €132,000 | €132,000 |
| Mortgage mandates | €1.2m | €1.2m |
| Carrying value of the mortgaged assets | €1.1m | €1.1m |
Source: notes to the 2024 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)
Investments
| Item | 2024 | 2025 |
|---|---|---|
| Tangible fixed assets | €1.9m | €11,820 |
| Intangible fixed assets | €26,499 | - |
| Financial fixed assets | €676 | - |
| Depreciation and write-downs of the year | €70,512 | €204,241 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Subsidies and aid
Flemish government
2024 · 1 entry · €4,800 awarded · €4,800 paidComparable companies
These companies have the same main activity as BIODENT: dental practice (NACE 86230). They are comparable in size and age: total assets between €1.2m and €2.1m, founded between 2021 and 2024.
| Company | Founded | Total assets | Equity | Gross margin | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|
| BIODENT Brasschaat | 2023 | €1.9m | €0.008m | €0.5m | €0.006m | 3.2 | 2025 |
| KS Ortho Antwerpen | 2021 | €1.7m | €1.1m | €0.6m | €0.2m | 3.2 | 2025 |
| BALI MAXILLO WAVRE Wavre | 2022 | €1.6m | €0.6m | €0.6m | €0.2m | 3.6 | 2025 |
| Orthodontie Desmedt Diksmuide | 2021 | €2.1m | €0.8m | €0.6m | €0.2m | 2.7 | 2025 |
| Tandzorg Vlaamse Ardennen Oudenaarde | 2021 | €1.8m | €0.5m | €0.4m | €0.2m | 2 | 2025 |
| TANDZORG PLUS Geel | 2023 | €1.2m | €0.2m | €0.5m | €0.02m | 5.1 | 2025 |
| Tandartsenpraktijk Turnova Turnhout | 2024 | €1.2m | -€0.04m | €0.5m | -€0.05m | 4.8 | 2025 |
They were chosen from the 4,415 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Companies with the same profile, two years later
Historical observationIn July 2024, 2,135 companies had the same profile as BIODENT has now. Two years later, 5.2% had gone bankrupt and 92.1% were still going.
- Micro
- 2 to 5 years old
- solvency under 10%
- a profit under 5% of the balance sheet
Another 0.4% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of BIODENT itself is lower: 0.1% within 12 months. It rests on far more data about BIODENT than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,135 companies, not a prediction for BIODENT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Remuneration, social security and pensions62 | €23,957 | €163,968 | ▲ 584% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €70,512 | €204,241 | ▲ 190% |
| Other operating charges640/8 | €7,295 | €20,033 | ▲ 175% |
| Gross operating margin9900 | €36,756 | €468,167 | ▲ 13× |
| Operating profit (loss)9901 | -€65,008 | €79,925 | - |
| Financial income75/76B | €22 | €18 | ▼ 18.7% |
| Recurring financial income75 | €22 | €18 | ▼ 18.7% |
| Financial charges65/66B | €53,579 | €73,761 | ▲ 37.7% |
| Recurring financial charges65 | €53,579 | €73,741 | ▲ 37.6% |
| Non-recurring financial charges66B | - | €20 | - |
| Profit (loss) for the period before taxes9903 | -€118,566 | €6,181 | - |
| Profit (loss) for the period9904 | -€118,566 | €6,181 | - |
| Profit (loss) for the period to be appropriated9905 | -€118,566 | €6,181 | - |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €2.0m | €1.9m | ▼ 4.6% |
| Fixed assets21/28 | €1.9m | €1.7m | ▼ 10.1% |
| Intangible fixed assets21 | €0.02m | €0.01m | ▼ 40.4% |
| Tangible fixed assets22/27 | €1.9m | €1.7m | ▼ 9.8% |
| Land and buildings22 | €1.1m | €1.1m | ▼ 8.0% |
| Plant, machinery and equipment23 | €0.08m | €0.07m | ▼ 4.6% |
| Furniture and vehicles24 | €0.2m | €0.2m | ▼ 11.3% |
| Leasing and similar rights25 | €0.5m | €0.4m | ▼ 14.4% |
| Financial fixed assets28 | €0.001m | €0.001m | = |
| Current assets29/58 | €0.08m | €0.2m | ▲ 128% |
| Stocks and contracts in progress3 | €0.02m | €0.03m | ▲ 100% |
| Stocks30/36 | €0.02m | €0.03m | ▲ 100% |
| Amounts receivable within one year40/41 | €0.001m | €0.005m | ▲ 507% |
| Trade receivables40 | €0.001m | €0.005m | ▲ 628% |
| Other amounts receivable41 | €142 | - | - |
| Cash at bank and in hand54/58 | €0.06m | €0.1m | ▲ 130% |
| Deferred charges and accrued income490/1 | €0.002m | €0.005m | ▲ 127% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €2.0m | €1.9m | ▼ 4.6% |
| Equity10/15 | €0.001m | €0.008m | ▲ 431% |
| Contributions10/11 | €0.1m | €0.1m | = |
| Profit (loss) carried forward14 | -€0.1m | -€0.1m | ▲ 5.2% |
| Amounts payable17/49 | €2.0m | €1.9m | ▼ 4.9% |
| Amounts payable after more than one year17 | €1.8m | €1.6m | ▼ 8.9% |
| Financial debts170/4 | €1.7m | €1.6m | ▼ 7.8% |
| Other amounts payable178/9 | €0.06m | €0.04m | ▼ 42.4% |
| Amounts payable within one year42/48 | €0.2m | €0.2m | ▲ 38.0% |
| Current portion of amounts payable after more than one year42 | €0.1m | €0.1m | ▲ 5.9% |
| Trade debts44 | €0.03m | €0.06m | ▲ 112% |
| Suppliers440/4 | €0.03m | €0.06m | ▲ 112% |
| Advances received on contracts in progress46 | €0.01m | €0.02m | ▲ 25.0% |
| Taxes, remuneration and social security45 | - | €0.02m | - |
| Remuneration and social security454/9 | - | €0.02m | - |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | -€118,566 | €6,181 | - |
| + Depreciation and write-downs630 | €70,512 | €204,241 | ▲ 190% |
| Operating cash flow (approximation) | -€48,054 | €210,422 | - |
| Investment in fixed assets (approximation) | - | -€11,820 | - |
| Change in cash | - | €79,196 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.